FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094620 [Registered on: 11/09/2025] Trial Registered Prospectively
Last Modified On: 11/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison between Garbhaprada Yoga With And Without Naryana Taila Uttar Basti In Infertility 
Scientific Title of Study   Comparative Clinical Evaluation Of Garbhaprada Yoga With And Without Naryana Taila Uttar Basti On Ovulatory Factor In Infertility 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anjali Verma 
Designation  Assistant Professor 
Affiliation  Rishikul Campus Haridwar 
Address  PG Department of Prasuti Tantra Evum Stree Roga, Rishikul Campus, Haridwar, Uttarakhand Ayurved University
Haridwar
Hardwar
UTTARANCHAL
249401
India 
Phone  6398967773  
Fax    
Email  drvermaanjali@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anjali Verma 
Designation  Assistant Professor 
Affiliation  Rishikul Campus Haridwar 
Address  PG Department of Prasuti Tantra Evum Stree Roga, Rishikul Campus, Haridwar, Uttarakhand Ayurved University
Haridwar
Hardwar
UTTARANCHAL
249401
India 
Phone  6398967773  
Fax    
Email  drvermaanjali@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Manju Devi 
Designation  Post Graduation Scholar 
Affiliation  Rishikul Campus Haridwar 
Address  PG Department of Prasuti Tantra Evum Stree Roga, Rishikul Campus, Haridwar, Uttarakhand Ayurved University
Haridwar
Hardwar
UTTARANCHAL
249401
India 
Phone  07889685583  
Fax    
Email  yeshman27@gmail.com  
 
Source of Monetary or Material Support  
PG Department Of Prasuti Tantra Evum Stree Roga OPD No 9 Rishikul Campus Haridwar Devpura 249401 Uttarakhand Ayurved University Uttarakhand India 
 
Primary Sponsor  
Name  Rishikul Campus Haridwar 
Address  Rishikul Campus Haridwar Uttarakhand Ayurved University OPD No 9 Devpura Haridwar 249401 Uttarakhand India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr MANJU DEVI  RISHIKUL CAMPUS HARIDWAR  OPD No 9 PG Department of Prasuti Tantra Evum Stree Roga Uttarakhand Ayurved University Haridwar Uttarakhand 249401 India
Hardwar
UTTARANCHAL 
07889685583

yeshman27@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Uttarakhand Ayurved University   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N979||Female infertility, unspecified. Ayurveda Condition: VANDHYA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Garbhaprada Yoga, Reference: Yogaratnakar Uttardh Chapter 45 Verse 5 , Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: -Madhu Ksheer Ghrita ), Additional Information: -
2Comparator ArmProcedure-uttara-bastiH, उत्तर-बस्तिः (Procedure Reference: Kashyap Samhita Sidhi Sthana Chapter 7 Verse 11, Procedure details: Patient Adviced To Empty The Bladder And Lie In Lithotomy Position Aseptic Precautions Will Be Adopted During Procedure Cuscos Approximation Will Be Performed For Proper Visualisation Of Cervical External Os And Utrerine Sound Will Be Passed Through External Os To Find The Position Of Uterus Then The 5ml Medicated Oil Will Be Pushed Slowly With The Help Of IUI Cannula Fitted With Disposable Syringe And Then The Patient Will Be Kept In Head Low Position The Procedure Done For 6 Days For 2 Consecutive Cycle Total Of 12 Days)
(1) Medicine Name: Narayana Taila , Reference: Sharangdhar Samhita Chapter 9 Verse 109, Route: Vaginal, Dosage Form: Taila, Dose: 5(ml), Frequency: od, Duration: 12 Days
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  Married female patient age (20-40years) having infertility.
Primary and Secondary both types of female infertility due to ovulatory factor defect
 
 
ExclusionCriteria 
Details  Patent having pelvic disease such as PID, Fibroids, and Ovarian Cyst(more than 3cm)
Patient having Gross Congenital Deformities of reproductive tract i.e. uterus, cervix, vagina
Patient having any debilitating disorders like T.B, Anemia (Hb percent less than 8 gm per dl), Jaundice, Hypertension, Diabetes Mellitus, Thyroid dysfunction, Renal disorders, Cardiac Disease, Malignancies, STDs etc.
 
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Correction Of Ovulatory Defect  2 Months 
 
Secondary Outcome  
Outcome  TimePoints 
Conception  2 Months 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   26/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response (Others) - 

  6. For how long will this data be available start date provided 10-09-2026 and end date provided 02-01-2027?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - Nil
Brief Summary  

PREVIOUS AYURVEDA RESEARCHES INDIVIDUALLY PROVEN THAT THERE IS SIGNIFICANT EFFECT OF GARBHAPRADA YOGA (BY THE NAME BALADI CHURNA) AND NARAYANA TAILA (IN FORM OF UTTAR BASTI, NASYA AND MATRA BASTI) ON OVULATION IN FEMALE INFERTILITY. UTTAR BASTI IS A UNIQUE PROCEDURE, TO ADMINISTER DRUG DIRECTLY INTO UTERUS TO PROVIDE BEST POSSIBLE THERAPEUTIC DOSE ON AFFECTED SITE.

THIS STUDY IS A COMPARATIVE CLINICAL EVALUATION OF GARBHAPRADA YOGA WITH AND WITHOUT NARAYANA TAILA UTTARBASTI ON OVULATORY FACTOR IN INFERTILITY 
20 PATIENTS WILL BE TAKEN IN EACH GROUP A NARAYANA  TAILA  UTTARBASTI AND GARBHAPRADA YOGA CURNA ORALLY WILL BE GIVEN TO GROUP A AND GARBHAPRADA YOGA ORALLY WILL BE GIVEN TO GROUP B
UTTARBASTI OF 5ML NARAYANA TAIL IN ONE SITTING FOR 6 DAYS AND GARBHAPRADA YOGA 5GM FOR TWICE DAILY FOR 2 MONTHS
 
Close